Table 2 Correlation coefficients between the staging systems vs. the PFT parameters (FVC and DLCO at baseline and after 12 months of treatment)
Staging systems | FVC (baseline) | FVC (absolute change) | DLCO (baseline) | DLCO (absolute change) | ||||
|---|---|---|---|---|---|---|---|---|
Placebo | CYC | Placebo | CYC | Placebo | CYC | Placebo | CYC | |
MaxFib | −0.21 (0.15) | −0.16 (0.29) | −0.31 (0.88) | 0.34 (0.02) | −0.46 (0.001) | −0.44 (0.003) | −0.02 (0.88) | 0.13 (0.41) |
Goh and Wells unadjusted stratification | −0.05 (0.75) | −0.25 (0.09) | −0.21 (0.15) | 0.10 (0.50) | −0.48 (0.001) | −0.51 (0.001) | 0.003 (0.98) | 0.17 (0.27) |
QILD WL | −0.38 (0.008) | −0.08 (0.61) | −0.23 (0.12) | 0.41 (0.006) | −0.35 (0.01) | −0.07 (0.63) | −0.35 (0.02) | 0.12 (0.45) |
QILD ZM | −0.27 (0.07) | −0.19 (0.23) | −0.20 (0.17) | 0.40 (0.008) | −0.41 (0.005) | −0.24 (0.12) | −0.30 (0.04) | 0.25 (0.10) |
QLF WL | −0.17 (0.26) | −0.25 (0.11) | −0.22 (0.13) | 0.06 (0.62) | −0.22 (0.13) | −0.20 (0.20) | −0.10 (0.50) | 0.16 (0.32) |
QLF ZM | −0.45 (0.002) | −0.39 (0.02) | −0.15 (0.31) | 0.18 (0.23) | −0.43 (0.002) | −0.41 (0.005) | −0.22 (0.13) | 0.12 (0.45) |